Home>Topics>>Allergan sues Valeant, Ackman for alleged insider trading

Allergan sues Valeant, Ackman for alleged insider trading

Reuters: Business News

Fri, 1 Aug 2014

(Reuters) - Botox maker Allergan Inc on Friday accused rival Valeant Pharmaceuticals International and billionaire investor William Ackman of violating securities laws by using insider information as they prepared a takeover bid for the drug company.

Related Videos

  1. Why Activist Investors Matter

    Thu, 28 Feb 2013

    Shareholders should take note when activist investors make headlines as they have very high success rates in achieving their goals, according to 13D Activist Fund's Ken Squire.

Content Partners